The British College of Aesthetic Medicine (BCAM) has revealed the results of the 2021 Annual Clinical Review
The BCAM has been collecting and sharing data since the association was founded in 2001, working with the Department of Health and Social Care (DHSC) to provide insights to guide and inform government thinking, explains BCAM.
The 2021 audit covers under 299,000 individual treatment episodes conducted by 340 healthcare professionals, including 147,000 for botulinum toxin, which was found to be the top treatment conducted throughout the year, outlines the College. The audit has been expanded to ask more detailed questions regarding members’ patients and treatments.
The review highlighted the issues which BCAM members face when treating complications from procedures carried out by non-healthcare professionals. The audit showed that members reported 600 complications from other practitioners, with 77% caused by dermal fillers, 13% from botulinum toxin, 6.7% from laser and 3.2% from threads.
According to the audit, the top five treatments performed by BCAM members were toxin injections, hyaluronic acid dermal fillers, mesotherapy, platelet-rich plasma and laser and IPL treatments.
BCAM president Dr Uliana Gout said, “In our 20th anniversary year, we are delighted to share the results of the 2021 BCAM Annual Clinical Review. The College is pioneering data collection, sharing insights and trends with stakeholders including the DSHC to pursue its charitable aims of patient education and safety. We are proud to be leading with facts not opinions, making evidence-based decisions about BCAM’s strategies and informing the wider aesthetic medicine community about our members’ clinical activity.”
